Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Amazon.com, Inc.
WARNING LETTER
•Amazon.com, Inc.•July 30, 2024

Amazon.com, Inc. – FDA Warning Letter, Jul 30, 2024

Record Details

On July 25, 2024, the FDA issued a Warning Letter to Amazon concerning the distribution of unapproved new drug products. The FDA purchased "MÔOYAM TCA 50%" and "Skin Beauty Solutions lactic acid skin peel 90%" through www.amazon.com, which were distributed via Amazon's Fulfillment by Amazon service.

These products are classified as drugs under section 201(g)(1) of the FD&C Act due to their intended use for affecting body structure or function, as evidenced by claims on their labeling. The FDA states these products are not generally recognized as safe and effective for their intended uses, making them "new drugs" under section 201(p) of the FD&C Act.

Introducing or delivering these unapproved new drugs into interstate commerce without an FDA-approved application violates sections 301(d) and 505(a) of the FD&C Act. The FDA expressed concern about the public health risk posed by potent chemical peel products, citing adverse event reports of skin injuries requiring medical attention.

Amazon is responsible for investigating and preventing recurrence of these violations and ensuring compliance with federal law. The company must submit a written response within fifteen working days, detailing corrective actions taken to prevent the distribution of unapproved chemical peel drug products, including supporting documentation. Failure to address the matter may result in legal action, including seizure or injunction.

Company
Amazon.com, Inc.
Inspection date
July 30, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Tina Smith (Director)
View Company Profile

ID · 1707e083-9782-40aa-981a-c01387b198fe

Violation Codes5
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 355

Full citation text and observation details available on the Dashboard.

Other documents for Amazon.com, Inc.
  • WARNING_LETTER - 2025-04-29April 29, 2025
  • WARNING_LETTER - 2025-03-03March 3, 2025
  • WARNING_LETTER - 2023-12-20December 20, 2023
  • WARNING_LETTER - 2023-11-14November 14, 2023
  • WARNING_LETTER - 2023-08-18August 18, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amazon.com, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.